东方生物：方新成辞去公司第三届董事会董事、审计委员会委员职务

Group 1 - The company, Oriental Bio, announced the resignation of Mr. Fang Xincheng from its board of directors and audit committee due to personal reasons, effective immediately upon receipt of the resignation report [1] - The resignation will not affect the minimum number of directors required by law, ensuring the normal operation of the board [1] - For the fiscal year 2024, the company's revenue composition is 97.99% from the in vitro diagnostics industry and 2.01% from other businesses [1] Group 2 - As of the report, Oriental Bio has a market capitalization of 5.5 billion yuan [1]